Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Eledon Pharmaceuticals, Inc. | 30,870 | reported | 10 Jan 2035 | tx 5+188,167−3,430 |
| Alkermes plc. | 6,250 | reported | 04 Apr 2019 | tx 7+368,650−8,088 |
| UroGen Pharma Ltd. | 2,000 | reported | 26 May 2026 | tx 12+84,000−6,000 |
| Neos Therapeutics, Inc. | 0 | reported | 19 Mar 2021 | tx 6+82,860−82,860 |
| Urovant Sciences Ltd. | 0 | reported | 29 Mar 2021 | tx 9+933,212−933,212 |
| APPLIED GENETIC TECHNOLOGIES CORP | 0 | reported | 30 Nov 2022 | tx 2+25,000−25,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 26 May 2026 | EXERCISE | UroGen Pharma Ltd. | 2,000 | — | |
| 26 May 2026 | EXERCISE | UroGen Pharma Ltd. | 2,000 | 0.00 USD | deriv |
| 26 Feb 2025 | EXERCISE | UroGen Pharma Ltd. | 2,000 | — | |
| 26 Feb 2025 | EXERCISE | UroGen Pharma Ltd. | 2,000 | 0.00 USD | deriv |
| 10 Jan 2026 | EXERCISE | Eledon Pharmaceuticals, Inc. | 3,430 | 0.00 USD | |
| 10 Jan 2026 | EXERCISE | Eledon Pharmaceuticals, Inc. | 3,430 | 0.00 USD | deriv |
| 26 Nov 2025 | EXERCISE | UroGen Pharma Ltd. | 2,000 | — | |
| 26 Nov 2025 | EXERCISE | UroGen Pharma Ltd. | 2,000 | 0.00 USD | deriv |
| 26 Aug 2025 | GRANT_AWARD | UroGen Pharma Ltd. | 10,000 | 0.00 USD | deriv |
| 26 Aug 2025 | GRANT_AWARD | UroGen Pharma Ltd. | 8,000 | 0.00 USD | deriv |
| 10 Jan 2025 | GRANT_AWARD | Eledon Pharmaceuticals, Inc. | 3,430 | 0.00 USD | deriv |
| 10 Jan 2035 | GRANT_AWARD | Eledon Pharmaceuticals, Inc. | 30,870 | 0.00 USD | deriv |
| 06 Aug 2024 | GRANT_AWARD | UroGen Pharma Ltd. | 10,000 | 0.00 USD | deriv |
| 02 Oct 2023 | GRANT_AWARD | Eledon Pharmaceuticals, Inc. | 150,437 | 1.55 USD | deriv |
| 07 Sept 2023 | GRANT_AWARD | UroGen Pharma Ltd. | 10,000 | 0.00 USD | deriv |
| 25 Jul 2023 | GRANT_AWARD | UroGen Pharma Ltd. | 20,000 | 0.00 USD | deriv |
| 30 Nov 2022 | OTHER | APPLIED GENETIC TECHNOLOGIES CORP | 25,000 | — | deriv |
| 30 Nov 2021 | GRANT_AWARD | APPLIED GENETIC TECHNOLOGIES CORP | 25,000 | 0.00 USD | deriv |
| 29 Mar 2021 | OTHER | Urovant Sciences Ltd. | 8,385 | — | |
| 29 Mar 2021 | OTHER | Urovant Sciences Ltd. | 25,000 | 0.00 USD | deriv |
| 29 Mar 2021 | OTHER | Urovant Sciences Ltd. | 50,000 | 0.00 USD | deriv |
| 29 Mar 2021 | OTHER | Urovant Sciences Ltd. | 845,732 | 0.00 USD | deriv |
| 19 Mar 2021 | OTHER | Neos Therapeutics, Inc. | 23,453 | — | |
| 19 Mar 2021 | OTHER | Neos Therapeutics, Inc. | 46,907 | 0.00 USD | deriv |
| 19 Mar 2021 | OTHER | Neos Therapeutics, Inc. | 12,500 | 0.00 USD | deriv |